Exploring the Mechanisms of Neuronal Protection by Glial Cell Line-Derived Neurotrophic Factor in Autism Spectrum...

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Autism spectrum disorder (ASD) is a complex neurological condition characterized by social interaction, communication, and behavioral challenges.
• Genetic factors, including neurotrophic genes like glial cell line-derived neurotrophic factor (GDNF), are implicated in ASD's neural protective mechanisms.

Purpose of the Study:

• To investigate the association between GDNF gene expression and serum levels with cognitive function in ASD patients.
• To evaluate the relationship between GDNF and neuronal protection using Mini-Mental State Examination (MMSE) scores.

Main Methods:

• A case-control study involving 100 ASD patients and 40 healthy controls.
• Analysis of GDNF gene expression using real-time quantitative polymerase chain reaction (qPCR).
• Measurement of serum GDNF levels via enzyme-linked immunosorbent assay (ELISA) and cognitive assessment using MMSE scores.

Main Results:

• ASD patients exhibited significantly lower serum GDNF levels (9.371 ± 2.388 pg/ml) compared to controls (27.1 ± 2.1).
• Lower GDNF levels correlated with more severe cognitive and behavioral deficits, as indicated by lower MMSE scores (13.6 ± 3.5) in ASD patients.
• Relative GDNF gene fold expression was lower in ASD patients (5.51) than in healthy individuals (11.71).

Conclusions:

• A notable decrease in GDNF gene expression and serum levels occurs in individuals with ASD.
• GDNF appears crucial for cognitive performance and neuronal protection in ASD.
• GDNF may serve as a potential biomarker for ASD diagnosis and understanding its molecular underpinnings.